chrisvoncsefalvay/vaers-outcomes huggingface dataset:
droopy; She did not feel well the day after the booster dose; something red in the urine/blood in her urine; nauseated; headache; tired; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (droopy), FEELING ABNORMAL (She did not feel well the day after the booster dose), BLOOD URINE PRESENT (something red in the urine/blood in her urine), NAUSEA (nauseated) and HEADACHE (headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004F21A, 042L20A and 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included INFLUENZA VACCINE from 05-Nov-2021 to 05-Nov-2021 for Flu prevention.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Nov-2021, the patient experienced ASTHENIA (droopy), FEELING ABNORMAL (She did not feel well the day after the booster dose), BLOOD URINE PRESENT (something red in the urine/blood in her urine), NAUSEA (nauseated), HEADACHE (headache) and FATIGUE (tired). The patient was treated with IBUPROFEN (IBUPROFEN 2CARE4) on 06-Nov-2021 for Adverse event, at an unspecified dose and frequency. At the time of the report, ASTHENIA (droopy), FEELING ABNORMAL (She did not feel well the day after the booster dose), NAUSEA (nauseated), HEADACHE (headache) and FATIGUE (tired) outcome was unknown and BLOOD URINE PRESENT (something red in the urine/blood in her urine) was resolving.            No concomitant medications were reported. No treatment information was provided.
Hair loss - severe with bald patches, ongoing loss. Muscle and joint pain, weakness, tremor in right upper extremity (where vaccine given), double vision, ataxia, hyperreflexia, headaches, dizziness.
Chills and headache first 24HRS after shot. Hard/swollen/red area on arm below injection site still remains 24HRS post injection.
exhausted; Low grade fever; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included 1st dose of BNT162B2 for COVID-19 immunization. Patient was exhausted after second vaccine and had a low-grade fever. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Immediately felt different than prior vaccinations. Felt like "hit a nerve". BANDAID placed 1 finger width from top of shoulder. No typical muscle soreness. Muscle stiffness and decreased range of motion within 1-2 days. Pain has persisted, range of motion is slightly improving but not back to baseline. Aches and throbs more at night to the point of awakening pt.
As reported by patient: "Within an hour, I had excruciating shoulder joint pain, which radiated into the collar bone and down the arm. It felt like a spear was being shoved into the joint in time with my pulse. This went on for 3 days, and began to lessen on the 4th. I was unable to lay down or sleep for 4 days. Last night was the 1st time I was able to lay down and sleep. Also, my BP skyrocketed. It hovered around 170 over 95 for the 1st 3 days, and around 160 over 90 on the 4th. Today it's 135 over 82, when I checked. I completely cut out coffee and any salt, and took Ramipril 2x daily, but it didn't bring it down. My left arm range of motion was nothing for almost 3 days. He had to help me dress. It is starting to come back. I can now lift my arm up to chest level."
When I first received  the vaccine  I felt tingling  on my ankles and it traveled to my knees  at first it was minimal  later the day passed and I felt do tired and I was really hot . I got a fever and I was very dehydrated.  I was dizzy and my joints jn my legs were so painful  and my muscles  on my back were so sore I decided  to sleep it off I woke up sweating.. I was still burning in fever with sever body soreness.  Now another day passed and im dizzy and tired with body aches
This spontaneous report was received from a registered nurse refers to an unspecified number of patients of unknown age. On 06-AUG-2015, the patients were vaccinated with an improperly stored dose of PNEUMOVAX 23 lot # K008410, expiry date 26-FEB-2016, K008409, expiry date 04-MAR-2015. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect storage and no adverse event to be related to PNEUMOVAX 23. No adverse reaction were reported. This is one of the 4 cases received from the same reporter. Additional information has been requested.
Nausea, stomach cramps developed 2/17/21. Chills and sweats developed during the incident.  Due to the number of days after vaccine, I did not initially think the symptoms might be related. Symptoms continued for over 24 hours.
(L) arm back of elbow, red, hot and tender 10cm x 8.5 cm. Tx: Dicloxacillin 500mg PO TID x 7 days
arm is just a little sore; women that gave the injection, she said you might want to keep an eye on your arm it was bubbling up, came home and did a little research, it said that could mean that you didn't get a full dose; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (arm is just a little sore) and INCORRECT DOSE ADMINISTERED (women that gave the injection, she said you might want to keep an eye on your arm it was bubbling up, came home and did a little research, it said that could mean that you didn't get a full dose) in a 63-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 015H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 03-Nov-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 03-Nov-2022, the patient experienced PAIN IN EXTREMITY (arm is just a little sore) and INCORRECT DOSE ADMINISTERED (women that gave the injection, she said you might want to keep an eye on your arm it was bubbling up, came home and did a little research, it said that could mean that you didn't get a full dose). At the time of the report, PAIN IN EXTREMITY (arm is just a little sore) and INCORRECT DOSE ADMINISTERED (women that gave the injection, she said you might want to keep an eye on your arm it was bubbling up, came home and did a little research, it said that could mean that you didn't get a full dose) outcome was unknown.            No concomitant drug was reported. Patient did a little research and that said that could mean that patient did not got a full dose. Patient was further asking was that true. No treatment drug was reported.
expired dose of Shingrix was administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 61-year-old female patient who received Herpes zoster (Shingrix) (batch number 9Y92A, expiry date 02-JUN-2023) for prophylaxis.   On 08-NOV-2023, the patient received Shingrix. On 08-NOV-2023, an unknown time after receiving Shingrix, the patient experienced expired vaccine used (Verbatim: expired dose of Shingrix was administered). The outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 8-Nov-2023 The reporter consented to follow-up via email. The patient received an expired dose of Shingrix, which led to expired vaccine used.
Information has been received from a physician concerning a 11 week old male who on 01-OCT-2007 was vaccinated PO with his first 2.0 mL dose of RotaTeq vaccine. On 17-OCT-2007, the patient experienced pain, vomiting and loose stools and was cranky and crying. Unspecified medical attention was sought. Subsequently, the patient recovered. There was no product quality complaint. This is one of several reports from the same source. Additional information has been requested.
both knees swollen to the size of a big softball; legs started to swell; within a couple days their ankles swollen; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (both knees swollen to the size of a big softball), PERIPHERAL SWELLING (legs started to swell) and JOINT SWELLING (within a couple days their ankles swollen) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Walker user. Concomitant products included SERTRALINE for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced JOINT SWELLING (both knees swollen to the size of a big softball), PERIPHERAL SWELLING (legs started to swell) and JOINT SWELLING (within a couple days their ankles swollen). The patient was treated with PARACETAMOL (TYLENOL ARTHRITIS) for Adverse event, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, JOINT SWELLING (both knees swollen to the size of a big softball), PERIPHERAL SWELLING (legs started to swell) and JOINT SWELLING (within a couple days their ankles swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  Corrective treatment included over the counter pain medication and extra strength tylenol.
Information has been received from a pharmacist concerning a 2 year old male child who in approximately 2001 was vaccinated with a dose of varicella virus vaccine live. Within 3 days of vaccination, the child developed a mild case of chickenpox. Unspecified medical attention was sought. Additional information has been requested.
In July 1999, post vax, he experienced left ankle swelling and was dx with cellulitis. He was treated with a cephalosporin but did not respond. He was subsequently treated with doxycline and an anti-inflammatory drug and he had inflammatory arthritis since he responded so well to treatment.
No seriousness criteria was reported. Based upon medical judgement this case is considered serious: medically significant event (OMIC). From initial information received on 1/30/04 from a registered nurse regarding an adverse event occurring in the USA, it was reported that a 32 year old female patient received MENOMUNE A/C/Y/W-135, lot number UB351AB, administered SC in the left arm at 2:30 PM on 1/28/04. One to two hours post-immunization, the patient complained of swollen eyes and lips. She took Benadryl orally at home. The next morning, on 1/29/04, the patient woke up with the feeling that her throat was swollen and complained of heaviness in her chest. She called her physician, who sent her to the emergency room for evaluation. The patient was treated with Solu-medrol, Benadryl, and an antacid and was released. Reportedly the patient recovered without further complaints.
This spontaneous report was received from a physician via company representative, and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 21-APR-2014, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 "10 Single dose 0.5mLVIs 10SDV" and lot number J009689 with expiration date of 29-JAN-2015 (route of administration was unknown), which was stored at 34 Fahrenheit (F) Degrees (1.111111111 Celsius) for a total of 144 hours and also at 33 Fahrenheit (F) Degrees (0.555555556 Celsius)for a total of 16 hours. The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effect were reported nor product quality complaint was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Patient reports left arm began hurting on 10/23/2003.  Then rash began on 10/24/2003.  10/27/2003 redness and swelling noted over entire upper left arm from elbow to shoulder.  Area also hot to touch.
No AEs; RN called to report temperature excursion that occurred on 7/12/2022. Caller states that 100 doses of PROQUAD and 94 doses of VARIVAX were administered since 7/12/2022 from mobile unit . No further information provided. No add; This spontaneous report was received from a nurse and refers to a child of unknown gender. The patient's concurrent conditions, medical history, allergies or concomitant therapies were not reported.  On 12-JUL-2022, 40 doses of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot # W002783 with expiration date 24-JUL-2023) underwent a temperature excursion during storage.   On an unknown date, the patient was one of 40 patients vaccinated with vaccine Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot # W002783  with expiration date 24-JUL-2023) administered as prophylaxis (dose regimen details were not provided).   No adverse event was reported. No further information was reported.  This is one of several reports received from the same reporter.
Information has been received from a physician concerning a 16 year old female who in the beginning of April 2008 was vaccinated with the first dose of GARDASIL.  It was reported that the patient experienced seizure, no time frame provided, and was hospitalized for a week to 10 days.  As of 16-SEP-2008, the outcome was unknown.  This is one of several reports received from the same source.  Additional information has been requested.
Shingles outbreak; Suspected vaccination failure; This case was reported by a lawyer and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix (unknown). On an unknown date, unknown after receiving Shingrix, the patient experienced shingles and vaccination failure (serious criteria GSK medically significant). The action taken with Shingrix was unknown. On an unknown date, the outcome of the shingles and vaccination failure were unknown.   It was unknown if the reporter considered the shingles and vaccination failure to be related to Shingrix.  Additional information: The age at vaccination was not reported. The patient received Shingrix and experienced shingles outbreak. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory test confirming shingles were not provided.
Initial unsolicited literature report received from a healthcare professional on 14 May 2015. A 40-year-old female patient, whose medical history reported as hypertension, hyperlipidemia and type 2 diabetes, had received a dose of Influenza Vaccine (batch number, expiration date, dose, dose cycle, route and site of administration were not reported) on an unspecified date. Patient had received ZOCOR, Metformin, Lisinopril/HCTZ, PREVACID and TOPROL XL as a concomitant medication. On unspecified date, after vaccination patient had experienced cough and flu-like symptoms for one week. On an unspecified date during second week, after vaccination patient had experienced fatigue, headaches, dizziness, abdominal pain, confusion and dark urination which were rendering unable to complete tasks at work. Patient also experienced shortness of breath and increased bruising. Patient was diagnosed with acute TTP caused by autoantibody mediated (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) ADAMTS-13 deficiency. Patient was initially admitted to a hospital for diarrhea, lightheadedness on an unspecified date. Laboratory investigation includes, platelet count result found as 10000, lactate dehydrogenase (LDH) result was found as 800, fibrinogen result was 419, schistocytes on peripheral smear, Coombs test result was negative, Human immunodeficiency virus (HIV) result was negative, creatinine level was normal, ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13): result less that 3%, hepatitis panel: result negative, at the time of discharge patient platelet count above 200. The patient had received Prednisone, Corticosteroids and plasmapheresis as a corrective treatment. During her fourth treatment, the patient had an anaphylactic reaction. She was started on high dose of prednisone and two additional rounds of plasmapheresis with good response. The patient got discharged from hospital on an unspecified date. At the time of this report, patient was recovered from all events on an unspecified date. List of the document held by sender: none.
Seizure and fever to 104- spontaneous resolution, pt discharged with Diastat.
Pertussis (DTaP/HIB/IPV) given in error 3 weeks in a row, very fussy and incolable x 24 hr after 3rd dose
Patient called and reported swelling of face and redness at injection site.  Patient went to see physician.  Patient received prednisone.  Blood work was good.
The pt experienced fussiness, not eating well, screaming. The pt was taken to the ER and had blood work and urine done. The pt refused spinal tap and was discharged. The pt was then seen by an "on call" pediatrician on 8/11 with a temp of 102.7 and was admitted to the medical center. A spinal tap was performed and the pt was treated with IV antibiotics. The pt had possible spinal meningitis.
Transient tenderness at injection site and swelling of shoulder, arm, and hand. Patient went to work immediately after receiving injection. Tenderness and swelling resolved overnite with ALEVE.
Extreme pain in lower back, inner thighs, feet and hands 8-10 hours. Tylenol relieved symptoms. Next day, backache, headache, queasy . Increased liquids, Tylenol
Around 7:00 P.M. on March 12, 2021 approximately 9 hours after receiving the Jansen COVD-19 vaccine in my left arm. I developed extreme fatigue, muscle aches, skin hurt to the touch of anything including clothing, headache, and fever 101.5.  I had to go to bed and was very weak.  I took ibuprofen and Tylenol for the discomfort.  I slept 14 hours and was able to get up at 11:00 A.M. on March 13, 2021.  The soreness at the site of the injection is not problematic.  There were other odd symptoms overnight I would awake with strange nerve like sensations tingling and itching that occurred on the bottom of the left foot, upper lip, and neck.  I also had several episodes of restlessness that was so bad that I had to stand for a few minutes before being able to lay down again.  The worst is the skin hurting and headache.  I have also had a few dizzy episodes since getting out of bed this morning.  It passes if I sit down or hold onto something.  None of these symptoms are normal for me and I cannot remember having a reaction to any vaccinations that I have received in the past.  I hope this helps with your study.
Pt received second dose of Moderna vaccine.  Lot # 026L20A at 1420.  Around 1425, patient experienced dizziness, lightheadedness, and warm feeling.  Pt was given water, and monitored for 30 minutes.  At that time, pt felt well, and left.  No additional monitoring or interventions required.
About 24 hours after her vaccines she developed urticaria over her whole body. They resolved after an additional 24 hours.
pt recv vax 16JAN97 & 5FEB97 pt exp a miscarriage;addtl details have been requested;
Once I received the vaccine 2 secs immediately started feeling flushed , blood rush going up to face, heart beat more rapid, and exp difficulty breathing. I spoke with staff was taken for a observation area and  had a EKG. While being observed after 5 mins felt as if I couldn't breathe. Around the 5 of 10 mins mark started feeling better and at 10 mins felt totally fine.
genl weakness & swelling/soreness/erythema @ inject site are reported in a pt receiving 1 dose of fluogen vax on 1NOV93; pt exp above sx on 12NOV93 which persisted; This is 1 of 2 pt's reported @ this site; pt recovered
PT BROUGHT IN 24 HOURS POST INJECTION WITH LOCAL REACTION OF 3 X 5 PATCH RED RAISED HIVES OVER RIGHT DELTOID AND PRURITIS AT SITE.  NO RESPIRATORY S/S.
This spontaneous report was received from a nurse practitioner regarding a patient of unknown age and gender. There was no information on pertinent medical history and drug reactions or allergies. On 06-AUG-2014, patient was vaccinated with M-M-R II, lot # H014648, Expiry date: 03-AUG-2014, dose. 5 ml (millilitre) subcutaneously. No concomitant therapy reported. The patient was vaccinated with expired dose of M-M-R II. No adverse effect was reported. There was no product quality complaint involved. The outcome of the event was unknown. Additional information has been requested.
Report 2001016272-1 described injection site swelling in a three year old female who received Infanrix. The vaccinee was allergic to Zithromax. She had no medical history. She took no concomitant medications. On 06/29/2001, the vaccinee received her fifth 0.1 ml dose of Infanrix. The dose was inadvertently administered intradermally; the nurse who administered the vaccine thought it was a PPD test. Post-vaccination, on 06/29/2001, the vaccinee experienced "local erythema and swelling, but no fever of fussiness." Medical attention was required at a doctor's office. The reporter indicated that the adverse events were mild in intensity and were related to Infanrix. As of 07/20/2001, the outcome of the adverse events was resolved.
Email 11-17-17 patient wrote: "On Nov. 8 I visited your clinic and received a yellow fever vaccination. I had not side effects until Nov. 12, when I felt very lethargic and later found that I had a fever. On Nov. 12 and 13, by body temperature ranged from 101F to 102.5F. On Nov. 13, my temperature was close to normal. However, on Nov. 14 and even today, I am experiencing a low grade fever ranging from 99F to 100F. I am assuming that this is a side effect of the vaccination and have thus not been alarmed. Should I be? If this is related to the vaccine, how long should I expect it to persist? I don't seem to have any other symptoms; just the not-quite-normal feeling that comes from having an abnormal temperature. I would appreciate your comments." I spoke with patient who verified above. He stated that he did not feel sick just the low grade fever. I encouraged him to go to the emergency room and to contact his doctor immediately. Dr. aware. STAMARIL AE and VAERS report sent.
5 days p/vax pt devel rash on neck & under arms;also very fussy;rash was identical to one devel 1wk p/prev vax;